Is ISRG a good stock to buy? We came across a bullish thesis on Intuitive Surgical, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on ISRG. Intuitive Surgical, Inc.’s share was trading at $412.02 as of June 10th. ISRG’s trailing and forward P/E were 50.06 and 39.68 respectively according to Yahoo Finance.
Master Video/Shutterstock.com
Intuitive Surgical (ISRG) is the global leader in robotic-assisted surgery, with its da Vinci platform forming the core of a high-margin recurring revenue model driven by an expanding installed base. While consensus primarily views the company through procedure growth, the deeper investment case lies in the compounding economics of more than 9,000 installed systems generating recurring instruments, accessories, and service revenue across every procedure performed.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Procedure volumes continue to grow at double-digit rates globally, with ongoing penetration into general surgery, thoracic, and colorectal applications, while emerging markets remain underpenetrated and offer a long runway for adoption. The Ion bronchoscopy platform represents an additional growth vector, extending the same razor-and-blade model into lung nodule biopsy, where expanding screening programs are expected to significantly increase procedural demand over time.
The company’s moat is reinforced not by hardware alone but by deep workflow integration and long surgeon training cycles that make switching costs extremely high and embed the system into hospital operating rooms. Even though the market assigns a premium multiple, it still appears to underestimate the durability of procedure growth and the long-term value of the installed base, leaving room for meaningful re-rating if execution continues.
Overall, Intuitive Surgical is positioned as a structurally advantaged healthcare technology compounder with sustained growth visibility and significant upside potential driven by expanding global adoption and platform-based recurring revenue economics. It also benefits from a durable first-mover advantage in robotic surgery, ensuring continued procedure migration toward minimally invasive techniques across global healthcare systems over time materially.
Previously, we covered a bullish thesis on Intuitive Surgical, Inc. (ISRG) by Kontra Investment Xchange in December 2024, which highlighted key drivers including da Vinci system adoption, procedure growth, and expanding robotic surgery applications. ISRG’s stock price has depreciated by approximately 23.98% since our coverage. Variant_Invest shares a similar view but emphasizes installed base compounding, Ion platform expansion, and recurring revenue durability.
Intuitive Surgical, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 103 hedge fund portfolios held ISRG at the end of the first quarter which was 109 in the previous quarter. While we acknowledge the risk and potential of ISRG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ISRG and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
